Suprava TZ 562.5 mg Injection 1's Substitute
›
Macleods Pharmaceuticals Ltd
₹147
(₹26.46 per ml)
Medley Pharmaceuticals Ltd
₹74
(₹66.6 per unit)
Alkem Laboratories Ltd
₹124.5
(₹109.5 per unit)
Aristo Pharmaceuticals Pvt Ltd
₹140.5
(₹126.5 per unit)
₹147
(₹132.3 per unit)
Cipla Ltd
₹163
(₹146.7 per unit)
Patients may explore substitutes in the following scenarios:
Before you switch from Suprava TZ 562.5 mg Injection 1's to another medicine, here are some important points to keep in mind:
Same salt, different brands:
Most substitutes contain the same active ingredient - CEFTRIAXONE-500MG + TAZOBACTAM-62.5MG, but the fillers, coating, or manufacturing quality may vary slightly.
Consult your doctor first:
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Watch out for allergies or reactions:
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
Price ≠ effectiveness:
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Check the dosage form and strength:
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Suprava TZ 562.5 mg Injection 1's is a combination of two drugs: Ceftriaxone (antibiotic) and Tazobactum (beta-lactamase inhibitor) used to treat several bacterial infections. Ceftriaxone is a broad-spectrum antibiotic that acts against both aerobic (grow in the presence of oxygen) and anaerobic (grow in the absence of oxygen) gram-negative and gram-positive bacteria. It interferes with the formation of the bacterial cell wall (a protective covering) necessary for their survival. Thereby damages the bacterial cell wall and kills bacteria. Tazobactum is a beta-lactamase inhibitor that enhances the activity of ceftriaxone and decreases resistance.
The substitutes of Suprava TZ 562.5 mg Injection 1's contain the same active salt(s) - CEFTRIAXONE-500MG + TAZOBACTAM-62.5MG. However, they may differ in price, manufacturing quality, and inactive ingredients. Speak to your doctor to find a suitable option.
Switching to a generic substitute medicine in the place of Suprava TZ 562.5 mg Injection 1's is often possible if it has the same salt, strength, and dosage form. But always check with your doctor before making any changes to your medication.
Generics versions of Suprava TZ 562.5 mg Injection 1's are typically more affordable because they don’t include the original brand's research, development, and marketing costs. They contain the same active ingredient and are approved for safety and effectiveness.
Most people don’t notice any difference. However, some may react to different fillers or coatings. If you notice any unusual symptoms after switching, consult your doctor.
Make sure the new medicine has the same active salt, strength, dosage form. Always confirm the change with your doctor or pharmacist.
Substitutes of Suprava TZ 562.5 mg Injection 1's meet the same safety and efficacy standards as Suprava TZ 562.5 mg Injection 1's, but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.
Yes. Substitutes of Suprava TZ 562.5 mg Injection 1's may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.
Yes, it’s generally safe to switch between multiple substitutes of Suprava TZ 562.5 mg Injection 1's if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.
Yes, many people safely use substitutes of Suprava TZ 562.5 mg Injection 1's for long-term treatment. Just ensure it’s done under medical supervision.
If your symptoms stay under control or lab results remain stable, the substitute for Suprava TZ 562.5 mg Injection 1's is likely working well. Regular follow-ups with your doctor are important.
Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Suprava TZ 562.5 mg Injection 1's to its substitute. Always consult your doctor before switching.
Suprava TZ 562.5 mg Injection 1's contains Ceftriaxone and Tazobactum. Ceftriaxone is an antibiotic that works by interfering with the formation of the bacterial cell wall (a protective covering) that is necessary for their survival. Thereby damages the bacterial cell wall and kills bacteria. Tazobactum is a beta-lactamase inhibitor that enhances the activity of ceftriaxone and decreases resistance.
Suprava TZ 562.5 mg Injection 1's may interfere with urine test (for sugar) and Coomb’s test (blood test) giving false-positive results. Therefore, if you are about to undergo any laboratory tests, inform your doctor or lab technician that you are taking Suprava TZ 562.5 mg Injection 1's.
You are not recommended to take Suprava TZ 562.5 mg Injection 1's with streptomycin as co-administration of these two medicines may increase the risk of kidney damage. However, please consult your doctor before taking Suprava TZ 562.5 mg Injection 1's with other medicines to adjust the dose appropriately.
Suprava TZ 562.5 mg Injection 1's may cause diarrhoea as a common side effect. However, if the condition persists, worsens or notices blood or mucus in stools, avoid taking Suprava TZ 562.5 mg Injection 1's and consult a doctor immediately.
Suprava TZ 562.5 mg Injection 1's is not used to treat viral infections. Suprava TZ 562.5 mg Injection 1's is an antibiotic which is used to treat only bacterial infections.
Suprava TZ 562.5 mg Injection 1's should be used with caution in patients with kidney problems as it may increase the risk of adverse effects. Therefore, inform your doctor if you have any kidney problems before taking Suprava TZ 562.5 mg Injection 1's so that the dose may be adjusted accordingly.